Jump Financial’s LeMaitre Vascular LMAT Stock Holding History

Jump Financial’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.5M	Sell	15,600 -3,732	-19%	-$383K	0.01%	1011
2026 Q1	$2.11M	Buy	19,332 +14,361	+289%	+$1.37M	0.03%	630
2025 Q4	$403K	Sell	4,971 -10,329	-68%	-$889K	0.01%	1411
2025 Q3	$1.34M	Buy	15,300 +12,393	+426%	+$1.11M	0.02%	887
2025 Q2	$241K	Buy	+2,907	New	+$243K	﹤0.01%	1527
2024 Q4	–	Sell	-11,928	Closed	-$1.11M	–	1848
2024 Q3	$1.11M	Sell	11,928 -572	-5%	-$49.6K	0.02%	749
2024 Q2	$1.03M	Sell	12,500 -5,320	-30%	-$391K	0.02%	804
2024 Q1	$1.18M	Sell	17,820 -522	-3%	-$32.2K	0.03%	711
2023 Q4	$1.04M	Buy	18,342 +3,692	+25%	+$193K	0.03%	703
2023 Q3	$798K	Buy	14,650 +5,012	+52%	+$297K	0.03%	783
2023 Q2	$648K	Buy	+9,638	New	+$588K	0.02%	901
2021 Q4	–	Sell	-10,000	Closed	-$531K	–	1578
2021 Q3	$531K	Buy	10,000 +4,101	+70%	+$231K	0.04%	458
2021 Q2	$360K	Buy	+5,899	New	+$313K	0.03%	594
2021 Q1	–	Sell	-5,400	Closed	-$219K	–	1132
2020 Q4	$219K	Buy	+5,400	New	+$193K	0.04%	737

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jump Financial's LMAT Position: Q2 2026 in Review

Jump Financial reduced its LeMaitre Vascular (LMAT) stake by 19% in Q2 2026, selling an estimated $383K and leaving 15,600 shares worth $1.5M. The position accounts for 0.01% of the portfolio, ranked #1011.

Jump Financial first reported a position in LMAT in Q4 2020 and has held it in 14 quarters since. The position peaked at $2.11M in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Jump Financial held 15,600 shares of LeMaitre Vascular worth $1.5M as of Q2 2026.
Jump Financial sold 3,732 LeMaitre Vascular shares in Q2 2026, an estimated $383K.
LeMaitre Vascular made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1011 holding.
Jump Financial first reported a position in LeMaitre Vascular in Q4 2020 and has held it in 14 quarters since.
Jump Financial's LeMaitre Vascular position peaked at $2.11M in Q1 2026.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.